Global Ofatumumab Production, Demand and Key Producers, 2022-2028

December 2022 | 83 pages | ID: GB3997D51518EN
GlobalInfoResearch

Abstracts

It is a dosage form administered subcutaneously for the treatment of relapsing forms of multiple sclerosis in adults.

This report studies the global Ofatumumab production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Ofatumumab, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ofatumumab that contribute to its increasing demand across many markets.

The global Ofatumumab market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Ofatumumab total production and demand, 2017-2028, (K Units)

Global Ofatumumab total production value, 2017-2028, (USD Million)

Global Ofatumumab production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)

Global Ofatumumab consumption by region & country, CAGR, 2017-2028 & (K Units)

U.S. VS China: Ofatumumab domestic production, consumption, key domestic manufacturers and share

Global Ofatumumab production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)

Global Ofatumumab production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)

Global Ofatumumab production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)

This reports profiles key players in the global Ofatumumab market based on the following parameters – headquarters, production locations, products portfolio, Ofatumumab revenue, sales, average price and gross margin, recent developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ofatumumab market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Ofatumumab Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India

Global Ofatumumab Market, Segmentation by Type

• 20mg/1mL
• 20mg/0.4mL
• 100mg/5mL
• Others

Global Ofatumumab Market, Segmentation by Application

• Relapsing-remitting Multiple Sclerosis
• Clinically Isolated Syndrome
• Active Secondary Progressive Multiple Sclerosis
• Others

Companies Profiled:

• Glaxosmithkline Inc
• Novartis

Key Questions Answered

1. How big is the global Ofatumumab market?

2. What is the demand of the global Ofatumumab market?

3. What is the year over year growth of the global Ofatumumab market?

4. What is the production and production value of the global Ofatumumab market?

5. Who are the key producers in the global Ofatumumab market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Ofatumumab Introduction
1.2 World Ofatumumab Supply & Forecast
  1.2.1 World Ofatumumab Production Value (2017 & 2021 & 2028)
  1.2.2 World Ofatumumab Production (2017-2028)
  1.2.3 World Ofatumumab Pricing Trends (2017-2028)
1.3 World Ofatumumab Production by Region
  1.3.1 World Ofatumumab Production Value by Region (2017-2028)
  1.3.2 World Ofatumumab Production by Region (2017-2028)
  1.3.3 World Ofatumumab Average Price by Region (2017-2028)
  1.3.4 Britain Ofatumumab Production (2017-2028)
  1.3.5 Europe Ofatumumab Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Ofatumumab Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Ofatumumab Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Ofatumumab Demand (2017-2028)
2.2 World Ofatumumab Consumption by Region
  2.2.1 World Ofatumumab Consumption by Region (2017-2022)
  2.2.2 World Ofatumumab Consumption Forecast by Region (2023-2028)
2.3 United States Ofatumumab Consumption (2017-2028)
2.4 China Ofatumumab Consumption (2017-2028)
2.5 Europe Ofatumumab Consumption (2017-2028)
2.6 Japan Ofatumumab Consumption (2017-2028)
2.7 South Korea Ofatumumab Consumption (2017-2028)
2.8 ASEAN Ofatumumab Consumption (2017-2028)
2.9 India Ofatumumab Consumption (2017-2028)

3 WORLD OFATUMUMAB MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Ofatumumab Production Value by Manufacturer (2017-2022)
3.2 World Ofatumumab Production by Manufacturer (2017-2022)
3.3 World Ofatumumab Average Price by Manufacturer (2017-2022)
3.4 Ofatumumab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Ofatumumab Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Ofatumumab in 2021
  3.5.3 Global Concentration Ratios (CR8) for Ofatumumab in 2021
3.6 Ofatumumab Market: Overall Company Footprint Analysis
  3.6.1 Ofatumumab Market: Region Footprint
  3.6.2 Ofatumumab Market: Company Product Type Footprint
  3.6.3 Ofatumumab Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Ofatumumab Production Value Comparison
  4.1.1 United States VS China: Ofatumumab Production Value Comparison (2017 & 2021 & 2028)
  4.1.2 United States VS China: Ofatumumab Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Ofatumumab Production Comparison
  4.2.1 United States VS China: Ofatumumab Production Comparison (2017 & 2021 & 2028)
  4.2.2 United States VS China: Ofatumumab Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Ofatumumab Consumption Comparison
  4.3.1 United States VS China: Ofatumumab Consumption Comparison (2017 & 2021 & 2028)
  4.3.2 United States VS China: Ofatumumab Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Ofatumumab Key Producers and Market Share, 2017-2022
  4.4.1 Major Manufacturer of Ofatumumab in United States, Company Headquarters and Production Place (States, Country)
  4.4.2 United States Ofatumumab Production Value by Domestic Manufacturer, (2017-2022)
  4.4.3 United States Ofatumumab Production by Domestic Manufacturer, (2017-2022)
4.5 China Ofatumumab Key Producers and Market Share, 2017-2022
  4.5.1 Major Manufacturer of Ofatumumab in China, Company Headquarters and Production Place (Province, Country)
  4.5.2 China Ofatumumab Production Value by Domestic Manufacturer, (2017-2022)
  4.5.3 China Ofatumumab Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Ofatumumab Key Producers and Market Share, 2017-2022
  4.6.1 Major Manufacturer of Ofatumumab in Rest of World, Company Headquarters and Production Place (State, Country)
  4.6.2 Rest of World Ofatumumab Production Value by Domestic Manufacturer, (2017-2022)
  4.6.3 Rest of World Ofatumumab Production by Domestic Manufacturer, (2017-2022)

5 MARKET ANALYSIS BY TYPE

5.1 World Ofatumumab Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
  5.2.1 20mg/1mL
  5.2.2 20mg/0.4mL
  5.2.3 100mg/5mL
  5.2.4 Others
5.3 Market Segment by Type
  5.3.1 World Ofatumumab Production by Type (2017-2028)
  5.3.2 World Ofatumumab Production Value by Type (2017-2028)
  5.3.3 World Ofatumumab Average Price by Type (2017-2028)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Ofatumumab Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
  6.2.1 Relapsing-remitting Multiple Sclerosis
  6.2.2 Clinically Isolated Syndrome
  6.2.3 Active Secondary Progressive Multiple Sclerosis
  6.2.4 Others
6.3 Market Segment by Application
  6.3.1 World Ofatumumab Production by Application (2017-2028)
  6.3.2 World Ofatumumab Production Value by Application (2017-2028)
  6.3.3 World Ofatumumab Average Price by Application (2017-2028)

7 COMPANY PROFILES

7.1 Glaxosmithkline Inc
  7.1.1 Glaxosmithkline Inc Details
  7.1.2 Glaxosmithkline Inc Major Business
  7.1.3 Glaxosmithkline Inc Ofatumumab Product and Services
  7.1.4 Glaxosmithkline Inc Ofatumumab Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.1.5 Glaxosmithkline Inc Recent Developments/Updates
  7.1.6 Glaxosmithkline Inc Competitive Strengths & Weaknesses
7.2 Novartis
  7.2.1 Novartis Details
  7.2.2 Novartis Major Business
  7.2.3 Novartis Ofatumumab Product and Services
  7.2.4 Novartis Ofatumumab Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.2.5 Novartis Recent Developments/Updates
  7.2.6 Novartis Competitive Strengths & Weaknesses

8 RAW MATERIAL AND INDUSTRY CHAIN

8.1 Raw Material of Ofatumumab and Key Manufacturers
8.2 Ofatumumab Manufacturing Costs
8.3 Ofatumumab Production Process
8.4 Ofatumumab Industrial Chain

9 DISTRIBUTION CHANNEL ANALYSIS

9.1 Distribution Channel Breakdown for Ofatumumab Shipments (%): 2017-2028
  9.1.1 Direct Channel
  9.1.2 Indirect Channel
9.2 Ofatumumab Typical Distributors
9.3 Ofatumumab Typical Customers

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Ofatumumab Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Ofatumumab Production Value by Region (2017-2022) & (USD Million)
Table 3. World Ofatumumab Production Value by Region (2023-2028) & (USD Million)
Table 4. World Ofatumumab Production Value Market Share by Region (2017-2022)
Table 5. World Ofatumumab Production Value Market Share by Region (2023-2028)
Table 6. World Ofatumumab Production by Region (2017-2022) & (K Units)
Table 7. World Ofatumumab Production by Region (2023-2028) & (K Units)
Table 8. World Ofatumumab Production Market Share by Region (2017-2022)
Table 9. World Ofatumumab Production Market Share by Region (2023-2028)
Table 10. World Ofatumumab Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Ofatumumab Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Ofatumumab Major Market Trends
Table 13. World Ofatumumab Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Ofatumumab Consumption by Region (2017-2022) & (K Units)
Table 15. World Ofatumumab Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Ofatumumab Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Ofatumumab Producers in 2021
Table 18. World Ofatumumab Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Ofatumumab Producers in 2021
Table 20. World Ofatumumab Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Ofatumumab Company Evaluation Quadrant
Table 22. World Ofatumumab Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Ofatumumab Production Site of Key Manufacturer
Table 24. Ofatumumab Market: Company Product Type Footprint
Table 25. Ofatumumab Market: Company Product Application Footprint
Table 26. Ofatumumab Competitive Factors
Table 27. Ofatumumab New Entrant and Capacity Expansion Plans
Table 28. Ofatumumab Mergers & Acquisitions Activity
Table 29. United States VS China Ofatumumab Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Ofatumumab Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Ofatumumab Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Ofatumumab in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Ofatumumab Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Ofatumumab Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Ofatumumab Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Ofatumumab Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Ofatumumab in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Ofatumumab Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Ofatumumab Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Ofatumumab Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Ofatumumab Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Ofatumumab in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Ofatumumab Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Ofatumumab Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Ofatumumab Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Ofatumumab Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Ofatumumab Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Ofatumumab Production by Type (2017-2022) & (K Units)
Table 49. World Ofatumumab Production by Type (2023-2028) & (K Units)
Table 50. World Ofatumumab Production Value by Type (2017-2022) & (USD Million)
Table 51. World Ofatumumab Production Value by Type (2023-2028) & (USD Million)
Table 52. World Ofatumumab Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Ofatumumab Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Ofatumumab Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Ofatumumab Production by Application (2017-2022) & (K Units)
Table 56. World Ofatumumab Production by Application (2023-2028) & (K Units)
Table 57. World Ofatumumab Production Value by Application (2017-2022) & (USD Million)
Table 58. World Ofatumumab Production Value by Application (2023-2028) & (USD Million)
Table 59. World Ofatumumab Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Ofatumumab Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Glaxosmithkline Inc Basic Information, Manufacturing Base and Competitors
Table 62. Glaxosmithkline Inc Major Business
Table 63. Glaxosmithkline Inc Ofatumumab Product and Services
Table 64. Glaxosmithkline Inc Ofatumumab Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Glaxosmithkline Inc Recent Developments/Updates
Table 66. Novartis Basic Information, Manufacturing Base and Competitors
Table 67. Novartis Major Business
Table 68. Novartis Ofatumumab Product and Services
Table 69. Novartis Ofatumumab Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 70. Ofatumumab Raw Material
Table 71. Key Manufacturers of Ofatumumab Raw Materials
Table 72. Ofatumumab Typical Distributors
Table 73. Ofatumumab Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Ofatumumab Picture
Figure 2. World Ofatumumab Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Ofatumumab Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Ofatumumab Production (2017-2028) & (K Units)
Figure 5. World Ofatumumab Average Price (2017-2028) & (US$/Unit)
Figure 6. World Ofatumumab Production Value Market Share by Region (2017-2028)
Figure 7. World Ofatumumab Production Market Share by Region (2017-2028)
Figure 8. Britain Ofatumumab Production (2017-2028) & (K Units)
Figure 9. Europe Ofatumumab Production (2017-2028) & (K Units)
Figure 10. Ofatumumab Market Drivers
Figure 11. Factors Affecting Demand
Figure 12. World Ofatumumab Demand (2017-2028) & (K Units)
Figure 13. World Ofatumumab Consumption Market Share by Region (2017-2028)
Figure 14. United States Ofatumumab Consumption (2017-2028) & (K Units)
Figure 15. China Ofatumumab Consumption (2017-2028) & (K Units)
Figure 16. Europe Ofatumumab Consumption (2017-2028) & (K Units)
Figure 17. Japan Ofatumumab Consumption (2017-2028) & (K Units)
Figure 18. South Korea Ofatumumab Consumption (2017-2028) & (K Units)
Figure 19. ASEAN Ofatumumab Consumption (2017-2028) & (K Units)
Figure 20. India Ofatumumab Consumption (2017-2028) & (K Units)
Figure 21. Producer Shipments of Ofatumumab by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 22. Global Four-firm Concentration Ratios (CR4) for Ofatumumab Markets in 2021
Figure 23. Global Four-firm Concentration Ratios (CR8) for Ofatumumab Markets in 2021
Figure 24. United States VS China: Ofatumumab Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 25. United States VS China: Ofatumumab Production Market Share Comparison (2017 & 2021 & 2028)
Figure 26. United States VS China: Ofatumumab Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 27. Key Producers and Market Share of Ofatumumab in United States
Figure 28. Key Producers and Market Share of Ofatumumab in China
Figure 29. Key Producers and Market Share of Ofatumumab in Rest of World
Figure 30. World Ofatumumab Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 31. World Ofatumumab Production Value Market Share by Type in 2021
Figure 32. 20mg/1mL
Figure 33. 20mg/0.4mL
Figure 34. 100mg/5mL
Figure 35. Others
Figure 36. World Ofatumumab Production Market Share by Type (2017-2028)
Figure 37. World Ofatumumab Production Value Market Share by Type (2017-2028)
Figure 38. World Ofatumumab Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Ofatumumab Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Ofatumumab Production Value Market Share by Application in 2021
Figure 41. Relapsing-remitting Multiple Sclerosis
Figure 42. Clinically Isolated Syndrome
Figure 43. Active Secondary Progressive Multiple Sclerosis
Figure 44. Others
Figure 45. World Ofatumumab Production Market Share by Application (2017-2028)
Figure 46. World Ofatumumab Production Value Market Share by Application (2017-2028)
Figure 47. World Ofatumumab Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Ofatumumab in 2021
Figure 49. Manufacturing Process Analysis of Ofatumumab
Figure 50. Ofatumumab Industrial Chain
Figure 51. Distribution Channel Breakdown for Ofatumumab Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source